GoldenGolden
Takis (Company)

Takis (Company)

A biotechnology company with a focus on therapies for cancer. It was founded in 2009 and is located in Rome, Italy.

Company

Takis is a Rome-based biotechnology company with a stated focus of the research and development of therapeutic cancer vaccines against tumor antigens, which play a role in tumor development and maintenance. It conducts research and develops technology for the sectors of immunology, oncology, infectious diseases, and preclinical models.

COVID-19

The company uses its genetic technology for viruses and DNA fragments that can be harnessed for gene therapy and vaccinations. It is working with another biotechnology company, LineaRx, as well as its own subsidiary, Evvivax, to develop a polymerase chain reaction (PCR)-based DNA (LinearDNA) manufacturing system for a vaccine for COVID-19.

Timeline

People

Name
Role
LinkedIn

Luigi Aurisicchio

Further reading

Title
Author
Link
Type
Date

Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate

Web

April 2, 2020

Documentaries, videos and podcasts

Title
Date
Link

Takis NeoMatrix EIT HealthCatapult HD

November 26, 2019

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
May 7, 2020
News18
While Israel's defence ministry announced a breakthrough in the development of an antibody, Rome-based biotech firm Takis said vaccine tests had shown positive effects.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.